As COVID-19 vaccines roll out, Spartans continue their work on the front lines, testing, treating, and even manufacturing the vaccine. Addyson Ives, a biomedical laboratory science major from the Biomedical Laboratory Diagnostics Program at Michigan State University, is part of the Biological Operations team for Pfizer. She and her unit are on the front lines, manufacturing the COVID-19 vaccine.
Medical laboratory scientist honored at international art competition.
Picture a hospital or clinical laboratory. What do you see? Perhaps lab coats and gloves, test tubes and beakers, petri dishes and instruments. A clean, white, sterile world of medical equipment occupied by busy, dedicated professionals. But if you look closer you will find a world filled with vibrant colors and artistic ambitions.
According to one of the world’s first SARS-CoV-2 proficiency testing programs – an objective method for measuring a laboratory’s testing performance and result validity – indicates that these newly developed laboratory testing methods are highly accurate for detecting the novel coronavirus, providing confidence in results and assurance for the clinical and public health decisions based on these test results.
The Biomedical Laboratory Diagnostics (BLD) program at Michigan State University was recently awarded a Scholarships for Disadvantaged Students (SDS) Grant from the Health Resources and Services Administration (HRSA) for BLD’s project, SMiLeS: Support in Medical Laboratory Science to increase the number of students entering the clinical laboratory sciences workforce and specifically place many of these supported students into clinical training sites in medically underserved communities.